APA (7th ed.) Citation

Jackson, L. R., Masi, M. R., Selman, B. M., Sandusky, G. E., Zarrinmayeh, H., Das, S. K., . . . Veronesi, M. C. (2022). Use of multimodality imaging, histology, and treatment feasibility to characterize a transgenic Rag2-null rat model of glioblastoma. Frontiers in oncology, 12, 939260. https://doi.org/10.3389/fonc.2022.939260

Chicago Style (17th ed.) Citation

Jackson, Luke R., et al. "Use of Multimodality Imaging, Histology, and Treatment Feasibility to Characterize a Transgenic Rag2-null Rat Model of Glioblastoma." Frontiers in Oncology 12 (2022): 939260. https://doi.org/10.3389/fonc.2022.939260.

MLA (9th ed.) Citation

Jackson, Luke R., et al. "Use of Multimodality Imaging, Histology, and Treatment Feasibility to Characterize a Transgenic Rag2-null Rat Model of Glioblastoma." Frontiers in Oncology, vol. 12, 2022, p. 939260, https://doi.org/10.3389/fonc.2022.939260.